FeesSafety
Pluang+

Ceragon expands wireless portfolio with RADWIN's sub-6 GHz solutions for broader network flexibility

Market News
03 Nov 2026, 13:00 WIB
PRNewsWire
View Source
Bullish
Ceragon expands wireless portfolio with RADWIN's sub-6 GHz solutions for broader network flexibility

Ceragon has partnered with RADWIN to include sub-6 GHz wireless access solutions in its portfolio, complementing its existing microwave and millimeter-wave technologies. This collaboration allows Ceragon to offer a more complete range of wireless solutions, enhancing flexibility for service providers and private network operators in designing and expanding networks. Customers benefit from simplified sourcing, unified network management, and dedicated technical support. The expanded offerings will be available globally through Ceragon's sales channels, supporting diverse applications from broadband to critical infrastructure.

Ceragon's expansion of its wireless portfolio provides context for technology sector activity on Pluang. For readers following technology stocks, here is Pluang's market snapshot as of Nov 03, 2026 16:11 WIB: Out of 150 priced US technology stocks, 80 rose and 69 fell. Notable movers include WIX at USD 77.55 with a 3.47% gain and a typical hold time of 64 days, EXFY at USD 2.36 up 3.06% with a 42-day hold, and ASX at USD 37.98 down 3.04%, with Pluang order activity showing 53% sell and 47% buy, and a 50-day typical hold time.

More News

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex names Terrie Kellmeyer CEO to lead clinical growth and FDA engagement

Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...

Company Fundamentals
Bullish
1 hour ago
Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology to present at UBS Global Biopharma Conference on Nov 16-17, 2026

Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...

Market News
Bullish
1 hour ago
Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond expands smart city tech with LiDAR-powered operational twins and AI collaborations

Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...

Market News
Bullish
1 hour ago
Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones schedules Q3 2026 earnings call for Nov 4, open to investors and analysts.

Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...

Company Fundamentals
Neutral
2 hours ago
Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones to hold Q3 2026 financial results conference call on Nov 4

Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...

Company Fundamentals
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App